| Stereotactic body radiation therapy for inoperable early stage lung cancer R Timmerman, R Paulus, J Galvin, J Michalski, W Straube, J Bradley, ... Jama 303 (11), 1070-1076, 2010 | 2753 | 2010 |
| Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or … JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ... The lancet oncology 16 (2), 187-199, 2015 | 2005 | 2015 |
| Radiation dose–volume effects in the lung LB Marks, SM Bentzen, JO Deasy, JD Bradley, IS Vogelius, I El Naqa, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S70-S76, 2010 | 1219 | 2010 |
| Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancer J Bradley, WL Thorstad, S Mutic, TR Miller, F Dehdashti, BA Siegel, ... International Journal of Radiation Oncology* Biology* Physics 59 (1), 78-86, 2004 | 763 | 2004 |
| Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis DA Palma, S Senan, K Tsujino, RB Barriger, R Rengan, M Moreno, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 444-450, 2013 | 695 | 2013 |
| Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized … SG Chun, C Hu, H Choy, RU Komaki, RD Timmerman, SE Schild, ... Journal of Clinical Oncology 35 (1), 56, 2017 | 684 | 2017 |
| A method for the reconstruction of four‐dimensional synchronized CT scans acquired during free breathing DA Low, M Nystrom, E Kalinin, P Parikh, JF Dempsey, JD Bradley, S Mutic, ... Medical physics 30 (6), 1254-1263, 2003 | 649 | 2003 |
| Toxicity and outcome results of RTOG 9311: A phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non–small-cell lung … J Bradley, MV Graham, K Winter, JA Purdy, R Komaki, WH Roa, JK Ryu, ... International Journal of Radiation Oncology* Biology* Physics 61 (2), 318-328, 2005 | 593 | 2005 |
| Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response JA Ajani, K Winter, GS Okawara, JH Donohue, PWT Pisters, CH Crane, ... Journal of clinical oncology 24 (24), 3953-3958, 2006 | 525 | 2006 |
| In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM F Dehdashti, MA Mintun, JS Lewis, J Bradley, R Govindan, R Laforest, ... European journal of nuclear medicine and molecular imaging 30, 844-850, 2003 | 424 | 2003 |
| Long-term results of NRG oncology RTOG 0617: standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non–small-cell lung cancer JD Bradley, C Hu, RR Komaki, GA Masters, GR Blumenschein, SE Schild, ... Journal of Clinical Oncology 38 (7), 706, 2020 | 412 | 2020 |
| Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non–small-cell lung cancer: NRG oncology/RTOG 0813 trial A Bezjak, R Paulus, LE Gaspar, RD Timmerman, WL Straube, WF Ryan, ... Journal of Clinical Oncology 37 (15), 1316, 2019 | 408 | 2019 |
| Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus T Ritter, DJ Quint, S Senan, LE Gaspar, RU Komaki, CW Hurkmans, ... International Journal of Radiation Oncology* Biology* Physics 81 (5), 1442-1457, 2011 | 382 | 2011 |
| Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen L Henke, R Kashani, C Robinson, A Curcuru, T DeWees, J Bradley, ... Radiotherapy and Oncology 126 (3), 519-526, 2018 | 371 | 2018 |
| 18f-fdg pet definition of gross tumor volume for radiotherapy of non–small cell lung cancer: Is a single standardized uptake value threshold approach appropriate? KJ Biehl, FM Kong, F Dehdashti, JY Jin, S Mutic, I El Naqa, BA Siegel, ... Journal of Nuclear Medicine 47 (11), 1808-1812, 2006 | 355 | 2006 |
| Stereotactic body radiation therapy for operable early-stage lung cancer: findings from the NRG oncology RTOG 0618 trial RD Timmerman, R Paulus, HI Pass, EM Gore, MJ Edelman, J Galvin, ... JAMA oncology 4 (9), 1263-1266, 2018 | 323 | 2018 |
| Positron emission tomography in limited-stage small-cell lung cancer: a prospective study JD Bradley, F Dehdashti, MA Mintun, R Govindan, K Trinkaus, BA Siegel Journal of clinical oncology 22 (16), 3248-3254, 2004 | 306 | 2004 |
| Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma JD Bradley, N Ieumwananonthachai, JA Purdy, TH Wasserman, ... International Journal of Radiation Oncology* Biology* Physics 52 (1), 49-57, 2002 | 306 | 2002 |
| Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer TD Crabtree, CE Denlinger, BF Meyers, I El Naqa, J Zoole, AS Krupnick, ... The Journal of thoracic and cardiovascular surgery 140 (2), 377-386, 2010 | 296 | 2010 |
| Novel breathing motion model for radiotherapy DA Low, PJ Parikh, W Lu, JF Dempsey, SH Wahab, JP Hubenschmidt, ... International Journal of Radiation Oncology* Biology* Physics 63 (3), 921-929, 2005 | 273 | 2005 |
